MODIFIED HIV-1 ENVELOPE PROTEINS

摘要

The present invention relates to modified HIV-1 envelope proteins where one or more N­glycosylation sites have been deleted or modified, which produce a broadly cross reactive neutralizing response, their methods of use and antibodies which bind to these proteins. The invention also provides for nucleic acids, vectors, antibodies and pharmaceutical compositions that comprise said modified HIV-1 envelope proteins.